For treatment, intermittent hypoxic therapy could activate the adaptive process of hypoxia mediated by HIF-1α, which was helpful for the treatment of hypoxia-induced osteoporosis (Bergholt et al., 2021; Chen et al., 2021). The gene discussed is HIF1A; the disease is osteoporosis.